Lab Members

A multidisciplinary team dedicated to precision oncology and spatial biology research.

Principal Investigator

Anniina Färkkilä, MD PhD

Anniina Färkkilä, MD PhD

Tenure track Professor in Translational Gynecologic Oncology

Anniina Färkkilä, is an Assistant professor in translational gynecologic oncology and a Specialist in gynecology at the University of Helsinki, Finland. She completed her postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School in 2019. In 2018 she was awarded the Seth Wichmann award by the Finnish Gynecologic Society, and the Eero Saksela award by the Finnish Cancer Institute in 2022. She was the recipient of a prestigious ERC Starting grant in 2022. Dr. Färkkilä also works as a specialist for gynecologic oncology at the Helsinki University Hospital (HUH), participating in multiple clinical trials at the HUH Comprehensive cancer center. Dr. Färkkilä coordinates the prospective Oncosys-Ova trial, and leads the Ovarian cancer project in the iCAN Digital Precision Medicine Flagship. She is a board member at the Nordic Society of Gynecologic Oncology (NSGO), the National Molecular tumor board of Finnish Cancer Center (FICAN), and the translational working group of European Network of gynecological clinical trials (ENTOG) and Gynecologic Cancer Inter Group (GCIG). She is passionate about precision oncology, improving the treatment and outcomes of cancer patients, leadership, wellbeing, family and outdoor activities.

Staff Scientists

Anastasia Lundgren, MSc

Anastasia Lundgren, MSc

Lab Manager

Anastasia Lundgren coordinates the ONCOSYS-Ova sample collection.

Debashish Deb, MSc

Debashish Deb, MSc

IT Specialist

Debashish Deb coordinates CSC services, lab website, and databases.

Joonas Jukonen, PhD

Joonas Jukonen, PhD

Research Coordinator

Joonas Jukonen coordinates personnel and financials for the lab, and provides scientific support and mentoring for the students.

Maija Vääriskoski, MSc Midwife

Maija Vääriskoski, MSc Midwife

Clinical Research Coordinator

Maija coordinates the Clinical Team, supports patient enrollment and manages data registry development in the ONCOSYS-OVA trial

Saundarya (Saun) Shah, MSc

Saundarya (Saun) Shah, MSc

Spatial Profiling Manager

Saundarya Shah coordinates tCycIF, Xenium, and GeoMx experiments.

Postdoctoral Researchers

Candice Madiot, PhD

Candice Madiot, PhD

Postdoctoral Researcher

Candice’s research aims to develop long-term immunocompetent organoid models derived from patients in order to study the functional consequences of interactions between the tumor and its microenvironment (TME) in ovarian cancer.

Hanna Elomaa, PhD

Hanna Elomaa, PhD

Postdoctoral Researcher

Hanna studies the ovarian cancer immune microenvironment using spatial profiling techniques such as tCycIF and Xenium, integrating immune and clinical data. She previously focused on immune cell contexture in colorectal cancer.

Inga-Maria Launonen, MD, PhD

Inga-Maria Launonen, MD, PhD

Postdoctoral Researcher

Inga-Maria Launonen focus on the effects of homologous recombination deficiencies and DNA damage on the tumor-immune interactions in high-grade serous ovarian cancer.

Sara Palomino, PhD

Sara Palomino, PhD

Postdoctoral Researcher

Sara Palomino's research explores the role of the tumor microenvironment in ovarian cancer progression using spatial transcriptomics, network analysis, and systems medicine.

Doctoral Researchers

Ada Junquera, MSc

Ada Junquera, MSc

Doctoral Researcher

Ada Junquera's research explores how current therapies influence the tumor microenvironment and immune dynamics using spatial technologies, including tCycIF multiplexed imaging and GeoMx spatial transcriptomics.

Aleksandra Shabanova, MSc

Aleksandra Shabanova, MSc

Doctoral Researcher

Aleksandra Shabanova's research investigates antigen presentation–driven immune evasion to identify novel prognostic markers and therapeutic targets for personalized cancer treatment.

Andreas Hainari, BMed

Andreas Hainari, BMed

Doctoral Researcher

Andreas Hainari is combining his medical training with technical studies in bioinformation technology to investigate actionable genomic aberrations in high-grade serous ovarian cancer.

Anni Suoknuuti, BMed

Anni Suoknuuti, BMed

Doctoral Researcher

Anni Suoknuuti works on the FINPROVE clinical trial, focusing on integrating clinical and molecular data to understand treatment response to MEK inhibitors in gynecological cancers.

Ella Anttila, MD

Ella Anttila, MD

Doctoral Researcher

Ella Anttila's research focuses on identifying biomarkers that predict spontaneous regression in cervical intraepithelial neoplasia grade 2 (CIN2) using spatial and multi-omic profiling.

Iga Niemiec, MSc

Iga Niemiec, MSc

Doctoral Researcher

Iga Niemiec's research investigates immune escape mechanisms in high-grade serous ovarian cancer by integrating genetics, spatial imaging, and spatial transcriptomics.

Kürşat Birgin, MSc

Kürşat Birgin, MSc

Doctoral Researcher

Kürşat Birgin contributes to the research area “Mechanisms of ADC Response & Resistance” by establishing organoid co-culture models with T cells and cancer-associated fibroblasts and performing downstream experimental work and bioinformatic analyses.

María Hincapié Otero, MSc

María Hincapié Otero, MSc

Doctoral Researcher

María Hincapié Otero investigates how cancer-associated fibroblasts shape responses to emerging anticancer therapies using innovative, patient-specific 3D models.

Matilda Salko, MD

Matilda Salko, MD

Doctoral Researcher

Matilda Salko's research focus is high-grade serous ovarian cancer, with particular emphasis on homologous recombination deficiency testing and its clinical implications.

Naipunya Guruprasad, MSc

Naipunya Guruprasad, MSc

Doctoral Researcher

Naipunya Guruprasad's project focuses on single-cell and spatial biomarkers in cervical cancer to uncover drivers of progression and responses to immunotherapy.

Pablo Siliceo Portugal, MSc

Pablo Siliceo Portugal, MSc

Doctoral Researcher

Pablo Siliceo Portugal focuses on understanding early immunoregulatory processes that drive tumor development in homologous recombination deficient tumors.

Silja Kauppila, BMed

Silja Kauppila, BMed

Doctoral Researcher

Silja Kauppila focuses on tCycIF analyses for the FINPROVE data and DCIS samples to discover spatial patterns of tumor and immune cell interactions.

Wenqing Chen, MSc

Wenqing Chen, MSc

Doctoral Researcher

Wenqing Chen focuses on applying and evaluating computational methods to quantify tissue architecture in multiplexed images.

Zhihan Liang, MSc

Zhihan Liang, MSc

Doctoral Researcher

Zhihan Liang's project investigates the ovarian cancer tumor microenvironment with a focus on tertiary lymphatic structure related genetic and functional features.

Ziqi Kang, MSc

Ziqi Kang, MSc

Doctoral Researcher

Ziqi Kang's project focuses on profiling the tissue architecture and discovering spatial-related immune response mechanisms from multiplexed images.

Medical Students

Anni Härkönen, BMed

Anni Härkönen, BMed

Medical student

Anni Härkönen is a fourth-year medical student, and her main focus is working on the clinical data of the Oncosys-ova study.

Master's Students

Anni Lindfors, MSc

Anni Lindfors, MSc

Genetics Master's Programme

Anni Lindfors works with genomic data and currently focuses on normalization approaches for easier analysis, with research interests in omics studies and bioinformatics. She has a background in biotechnology and holds a master’s degree in Life Science Technologies from Aalto University.

Antti Toivanen, BSc

Antti Toivanen, BSc

LSI Master's Programme

Antti Toivanen's interests include bioinformatics, molecular biology, and systems modelling. His thesis focuses on evaluating the statistical power of tissue microarrays (TMAs) in sampling high-grade serous ovarian cancer.

Elias Ruuska, BSc

Elias Ruuska, BSc

Genetics Master's Programme

Elias Ruuska develops and applies t-CycIF image analysis pipelines to investigate spatial cell interactions within the tumor microenvironment.

Nika Mikhailava, BSc

Nika Mikhailava, BSc

Genetics Master's Programme

Nika Mikhailava's research focuses on identifying biomarkers that predict disease outcomes and therapeutic targets to overcome treatment resistance in patients with high-grade serous ovarian cancer.

Rami Lahtinen

Rami Lahtinen

Master's Student

Rami’s research focuses on the generalisability and capabilities of the SPACEstat pipeline. He has a background in complex systems and his interests include machine learning in medicine and all things nerdy.

Viktor Schwartz

Viktor Schwartz

Master's Student

Viktor Schwartz investigates antibody–drug conjugate (ADC) response and resistance in long-term organoid cultures and contributes to the development of co-culture systems with T cells and cancer-associated fibroblasts.

Trainees

Foteini Chamchougia, BSc

Foteini Chamchougia, BSc

Technical Assistant

Foteini Chamchougia contributes to patient sample processing and biobanking, and supports drug testing experiments using complex in vitro models of the HGSC tumor microenvironment to investigate drug response and resistance.

Noora Hautamäki, MSc

Noora Hautamäki, MSc

Research Assistant

Noora Hautamäki’s project focuses on computational integration of t-CycIF data with transcriptomic and genomic data to reveal patient-level patterns in high-grade serous ovarian cancer.

Clinical Researchers

Karen Ahlnäs, MSc Midwife

Karen Ahlnäs, MSc Midwife

Clinical Research Nurse

Karen Ahlnäs is a clinical research nurse responsible for data requests and reporting of samples to Helsinki Biobank.

Laura Haapasalo, Midwife

Laura Haapasalo, Midwife

Study Nurse

Laura Haapasalo is a midwife working with gynecological cancer patients at the Outpatient Clinic of the Women's Hospital.

Ulla-Maija Haltia, MD PhD

Ulla-Maija Haltia, MD PhD

Gynecologic Oncologist

Ulla-Maija Haltia specializes in ovarian cancer, dividing her time between patient care and translational research.

Alumni

Postdoctoral Researchers

Ashwini Nagaraj, PhD

Ashwini Nagaraj's research focused on establishing high-grade serous ovarian cancer patient-derived immunocompetent models for functional testing of immunotherapeutic agents.

Elina Pietilä, PhD

Elina Pietilä worked on precision medicine in high-grade serous ovarian cancer using immunocompetent patient-derived ex-vivo cultures.

Julia Casado, PhD

Julia Casado's research focused on the tumor microenvironment analysis from highly-multiplexed images, developing algorithms for cell type and state identification.

Doctoral Researchers

Fernando Perez, PhD

Fernando Perez's research focused on identifying genomic and tumor microenvironment biomarkers that predict chemotherapy response in ovarian cancer.

Staff

Aino Elomaa, BSc

Aino Elomaa coordinated the ONCOSYS-Ova sample collection as Laboratory and Clinical Sample Coordinator.

Angéla Szabó, MSc

Angéla Szabó's work focused on cell-type calling and image analysis.

Other Students

Abhilash VA, MSc

Abhilash VA performed evaluations of immune cell-specific functional responses in patient-derived immunocompetent cultures.

Aditi Sirsikar, BSc

Aditi Sirsikar's responsibilities included analyzing multi-dimensional drug response data from patient-derived immunocompetent cultures.

Alva Grönholm, BSc

Alva Grönholm focused on performing bioinformatic analyses for the cell cycle project on highly multiplexed imaging data.

Arttu Peltola, BSc

Arttu Peltola contributed to improving the image processing pipeline by developing a metric and framework to evaluate and optimize segmentation performance.

Assel Kalmenova, MSc

Assel Kalmenova worked on the expansion of high-grade serous ovarian cancer organoids and analysis of the tumor microenvironment.

Eveliina Holappa, BSc

Eveliina Holappa's tasks focused on patient sample processing, 3D cell culture, and flow cytometry experiments.

Foteini Chamchougia, MSc

Foteini Chamchougia was involved in multiple projects analyzing patient-derived samples using spatial techniques like tCycIF.

Gayani Anandagoda, BSc

Gayani Anandagoda applied bioinformatics and machine learning tools to spatial transcriptomic data to analyze the tumor microenvironment.

Lina Maltrovsky, BSc

Lina Maltrovsky focused on combining highly multiplexed imaging with proteomics analysis.

Maija Tissarinen, BSc

Maija Tissarinen focused on the data exploration and statistical integration of multiomics data to model overall patient clinical outcomes in high-grade serous ovarian cancer.

Matías Aiskovich, MSc

Matías Aiskovich applied bioinformatics and machine learning to tumor omics data, focusing on computer vision models for multiplexed imaging.

Olavi Goussev, MSc (Tech)

Olavi Goussev focused on the development of machine learning processes and feature engineering for analyzing tumor microenvironments.

Panagiotis Lilis, BSc

Panagiotis Lilis specialized in cell culture and establishing long-term 3D ovarian tumor organoid cultures.

Sarah Wolf, BSc

Sarah Wolf supported patient sample processing and biobanking, and assisted with drug testing in complex in vitro models of the tumor microenvironment.

Teodóra Faragó, MSc

Teodóra Faragó's tasks consisted of automatic cell-type calling and computational analysis.

Venla Kaislo, BSc

Venla Kaislo's research focused on omics data analysis and multimodal clinical modeling for ovarian cancer.